Synovial pathology in an ovine model of osteoarthritis : effect of intraarticular hyaluronan (Hyalgan®)

Published scoring methods for quantifying synovitis focus on acute inflammatory parameters, and are unsuitable as outcome measures in experimental surgical models of osteoarthritis (OA). The aim of the present study was to define a modified histopathological scoring system for ovine synovium more su...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental rheumatology 2008-07, Vol.26 (4), p.561-567
Hauptverfasser: CAKE, M. A, SMITH, M. M, YOUNG, A. A, SMITH, S. M, GHOSH, P, READ, R. A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 567
container_issue 4
container_start_page 561
container_title Clinical and experimental rheumatology
container_volume 26
creator CAKE, M. A
SMITH, M. M
YOUNG, A. A
SMITH, S. M
GHOSH, P
READ, R. A
description Published scoring methods for quantifying synovitis focus on acute inflammatory parameters, and are unsuitable as outcome measures in experimental surgical models of osteoarthritis (OA). The aim of the present study was to define a modified histopathological scoring system for ovine synovium more suited to the chronic pathology induced by ovine meniscectomy, and to apply it to detect any therapeutic effects following intraarticular injection of hyaluronan (HA) (Hyalgan). OA was induced in 12 sheep by bilateral lateral meniscectomy, before weekly intraarticular injections of HA or saline vehicle from 16-20 weeks post-operatively, prior to sacrifice at 26 weeks. Six matched sheep were used as controls. Synovial sections were qualitatively scored for hyperplasia, inflammatory infiltrate, fibrosis, and hypervascularity; cell number, depth of fibrosis, and vessel number were also quantified using a graticule. OA synovia had significantly elevated scores for inflammatory cell infiltration, subintimal fibrosis, vascularity, and aggregate score relative to controls. HA-treated sheep had significantly lower vascularity score (p=0.015), aggregate score (p=0.007), depth of fibrosis (p=0.003) and vessel number (p=0.048) compared to saline-injected sheep. This study confirms the presence of a chronic synovitis in this OA model, characterised by subintimal fibrosis and hypervascularity (but only modest infiltrate and minimal intimal hyperplasia), which is partially ameliorated by intraarticular hyaluronate therapy.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69582282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69582282</sourcerecordid><originalsourceid>FETCH-LOGICAL-p239t-f23376f685ddd5b2d565326e225b41f450593513e00c621ff104a6735f81e8553</originalsourceid><addsrcrecordid>eNo9kNFKwzAYhYMobk5fQXKj6EUhTfanqXcy1AkDL1TYXcnaZI1kSU1SoS_lQ_hkVpxenZ9zPg785wBNcyhZRkqxPkRTwkqaCeDrCTqJ8Y0QyoEXx2iSi6IsiYApap8H5z-MtLiTqfXWbwdsHJYOj65TeOcbZbHX2MekvAypDSaZiG-w0lrV6ScyLgU5RqburQy4HaTtg3djx9VyvLfSfX1en6IjLW1UZ3udodf7u5fFMls9PTwubldZR1mZMk0ZK7jmApqmgQ1tgAOjXFEKm3mu50DG_yBnipCa01zrnMwlLxhokSsBwGbo8re3C_69VzFVOxNrZa10yvex4iUISgUdwfM92G92qqm6YHYyDNXfNiNwsQdkrKXVQbraxH-OEi6KggD7BlSWbwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69582282</pqid></control><display><type>article</type><title>Synovial pathology in an ovine model of osteoarthritis : effect of intraarticular hyaluronan (Hyalgan®)</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>CAKE, M. A ; SMITH, M. M ; YOUNG, A. A ; SMITH, S. M ; GHOSH, P ; READ, R. A</creator><creatorcontrib>CAKE, M. A ; SMITH, M. M ; YOUNG, A. A ; SMITH, S. M ; GHOSH, P ; READ, R. A</creatorcontrib><description>Published scoring methods for quantifying synovitis focus on acute inflammatory parameters, and are unsuitable as outcome measures in experimental surgical models of osteoarthritis (OA). The aim of the present study was to define a modified histopathological scoring system for ovine synovium more suited to the chronic pathology induced by ovine meniscectomy, and to apply it to detect any therapeutic effects following intraarticular injection of hyaluronan (HA) (Hyalgan). OA was induced in 12 sheep by bilateral lateral meniscectomy, before weekly intraarticular injections of HA or saline vehicle from 16-20 weeks post-operatively, prior to sacrifice at 26 weeks. Six matched sheep were used as controls. Synovial sections were qualitatively scored for hyperplasia, inflammatory infiltrate, fibrosis, and hypervascularity; cell number, depth of fibrosis, and vessel number were also quantified using a graticule. OA synovia had significantly elevated scores for inflammatory cell infiltration, subintimal fibrosis, vascularity, and aggregate score relative to controls. HA-treated sheep had significantly lower vascularity score (p=0.015), aggregate score (p=0.007), depth of fibrosis (p=0.003) and vessel number (p=0.048) compared to saline-injected sheep. This study confirms the presence of a chronic synovitis in this OA model, characterised by subintimal fibrosis and hypervascularity (but only modest infiltrate and minimal intimal hyperplasia), which is partially ameliorated by intraarticular hyaluronate therapy.</description><identifier>ISSN: 0392-856X</identifier><identifier>EISSN: 1593-098X</identifier><identifier>PMID: 18799085</identifier><language>eng</language><publisher>Pisa: Clinical and Experimental Rheumatology</publisher><subject>Animals ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Case-Control Studies ; Disease Models, Animal ; Diseases of the osteoarticular system ; Female ; Fibrosis - drug therapy ; Hyaluronic Acid - administration &amp; dosage ; Hyperplasia - drug therapy ; Injections, Intra-Articular ; Medical sciences ; Miscellaneous. Osteoarticular involvement in other diseases ; Osteoarthritis ; Osteoarthritis - drug therapy ; Osteoarthritis - pathology ; Pharmacology. Drug treatments ; Severity of Illness Index ; Sheep, Domestic ; Synovial Membrane - drug effects ; Synovial Membrane - pathology ; Viscosupplements - administration &amp; dosage</subject><ispartof>Clinical and experimental rheumatology, 2008-07, Vol.26 (4), p.561-567</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20687705$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18799085$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CAKE, M. A</creatorcontrib><creatorcontrib>SMITH, M. M</creatorcontrib><creatorcontrib>YOUNG, A. A</creatorcontrib><creatorcontrib>SMITH, S. M</creatorcontrib><creatorcontrib>GHOSH, P</creatorcontrib><creatorcontrib>READ, R. A</creatorcontrib><title>Synovial pathology in an ovine model of osteoarthritis : effect of intraarticular hyaluronan (Hyalgan®)</title><title>Clinical and experimental rheumatology</title><addtitle>Clin Exp Rheumatol</addtitle><description>Published scoring methods for quantifying synovitis focus on acute inflammatory parameters, and are unsuitable as outcome measures in experimental surgical models of osteoarthritis (OA). The aim of the present study was to define a modified histopathological scoring system for ovine synovium more suited to the chronic pathology induced by ovine meniscectomy, and to apply it to detect any therapeutic effects following intraarticular injection of hyaluronan (HA) (Hyalgan). OA was induced in 12 sheep by bilateral lateral meniscectomy, before weekly intraarticular injections of HA or saline vehicle from 16-20 weeks post-operatively, prior to sacrifice at 26 weeks. Six matched sheep were used as controls. Synovial sections were qualitatively scored for hyperplasia, inflammatory infiltrate, fibrosis, and hypervascularity; cell number, depth of fibrosis, and vessel number were also quantified using a graticule. OA synovia had significantly elevated scores for inflammatory cell infiltration, subintimal fibrosis, vascularity, and aggregate score relative to controls. HA-treated sheep had significantly lower vascularity score (p=0.015), aggregate score (p=0.007), depth of fibrosis (p=0.003) and vessel number (p=0.048) compared to saline-injected sheep. This study confirms the presence of a chronic synovitis in this OA model, characterised by subintimal fibrosis and hypervascularity (but only modest infiltrate and minimal intimal hyperplasia), which is partially ameliorated by intraarticular hyaluronate therapy.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Case-Control Studies</subject><subject>Disease Models, Animal</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>Fibrosis - drug therapy</subject><subject>Hyaluronic Acid - administration &amp; dosage</subject><subject>Hyperplasia - drug therapy</subject><subject>Injections, Intra-Articular</subject><subject>Medical sciences</subject><subject>Miscellaneous. Osteoarticular involvement in other diseases</subject><subject>Osteoarthritis</subject><subject>Osteoarthritis - drug therapy</subject><subject>Osteoarthritis - pathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Severity of Illness Index</subject><subject>Sheep, Domestic</subject><subject>Synovial Membrane - drug effects</subject><subject>Synovial Membrane - pathology</subject><subject>Viscosupplements - administration &amp; dosage</subject><issn>0392-856X</issn><issn>1593-098X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kNFKwzAYhYMobk5fQXKj6EUhTfanqXcy1AkDL1TYXcnaZI1kSU1SoS_lQ_hkVpxenZ9zPg785wBNcyhZRkqxPkRTwkqaCeDrCTqJ8Y0QyoEXx2iSi6IsiYApap8H5z-MtLiTqfXWbwdsHJYOj65TeOcbZbHX2MekvAypDSaZiG-w0lrV6ScyLgU5RqburQy4HaTtg3djx9VyvLfSfX1en6IjLW1UZ3udodf7u5fFMls9PTwubldZR1mZMk0ZK7jmApqmgQ1tgAOjXFEKm3mu50DG_yBnipCa01zrnMwlLxhokSsBwGbo8re3C_69VzFVOxNrZa10yvex4iUISgUdwfM92G92qqm6YHYyDNXfNiNwsQdkrKXVQbraxH-OEi6KggD7BlSWbwg</recordid><startdate>20080701</startdate><enddate>20080701</enddate><creator>CAKE, M. A</creator><creator>SMITH, M. M</creator><creator>YOUNG, A. A</creator><creator>SMITH, S. M</creator><creator>GHOSH, P</creator><creator>READ, R. A</creator><general>Clinical and Experimental Rheumatology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20080701</creationdate><title>Synovial pathology in an ovine model of osteoarthritis : effect of intraarticular hyaluronan (Hyalgan®)</title><author>CAKE, M. A ; SMITH, M. M ; YOUNG, A. A ; SMITH, S. M ; GHOSH, P ; READ, R. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p239t-f23376f685ddd5b2d565326e225b41f450593513e00c621ff104a6735f81e8553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Case-Control Studies</topic><topic>Disease Models, Animal</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>Fibrosis - drug therapy</topic><topic>Hyaluronic Acid - administration &amp; dosage</topic><topic>Hyperplasia - drug therapy</topic><topic>Injections, Intra-Articular</topic><topic>Medical sciences</topic><topic>Miscellaneous. Osteoarticular involvement in other diseases</topic><topic>Osteoarthritis</topic><topic>Osteoarthritis - drug therapy</topic><topic>Osteoarthritis - pathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Severity of Illness Index</topic><topic>Sheep, Domestic</topic><topic>Synovial Membrane - drug effects</topic><topic>Synovial Membrane - pathology</topic><topic>Viscosupplements - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CAKE, M. A</creatorcontrib><creatorcontrib>SMITH, M. M</creatorcontrib><creatorcontrib>YOUNG, A. A</creatorcontrib><creatorcontrib>SMITH, S. M</creatorcontrib><creatorcontrib>GHOSH, P</creatorcontrib><creatorcontrib>READ, R. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CAKE, M. A</au><au>SMITH, M. M</au><au>YOUNG, A. A</au><au>SMITH, S. M</au><au>GHOSH, P</au><au>READ, R. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synovial pathology in an ovine model of osteoarthritis : effect of intraarticular hyaluronan (Hyalgan®)</atitle><jtitle>Clinical and experimental rheumatology</jtitle><addtitle>Clin Exp Rheumatol</addtitle><date>2008-07-01</date><risdate>2008</risdate><volume>26</volume><issue>4</issue><spage>561</spage><epage>567</epage><pages>561-567</pages><issn>0392-856X</issn><eissn>1593-098X</eissn><abstract>Published scoring methods for quantifying synovitis focus on acute inflammatory parameters, and are unsuitable as outcome measures in experimental surgical models of osteoarthritis (OA). The aim of the present study was to define a modified histopathological scoring system for ovine synovium more suited to the chronic pathology induced by ovine meniscectomy, and to apply it to detect any therapeutic effects following intraarticular injection of hyaluronan (HA) (Hyalgan). OA was induced in 12 sheep by bilateral lateral meniscectomy, before weekly intraarticular injections of HA or saline vehicle from 16-20 weeks post-operatively, prior to sacrifice at 26 weeks. Six matched sheep were used as controls. Synovial sections were qualitatively scored for hyperplasia, inflammatory infiltrate, fibrosis, and hypervascularity; cell number, depth of fibrosis, and vessel number were also quantified using a graticule. OA synovia had significantly elevated scores for inflammatory cell infiltration, subintimal fibrosis, vascularity, and aggregate score relative to controls. HA-treated sheep had significantly lower vascularity score (p=0.015), aggregate score (p=0.007), depth of fibrosis (p=0.003) and vessel number (p=0.048) compared to saline-injected sheep. This study confirms the presence of a chronic synovitis in this OA model, characterised by subintimal fibrosis and hypervascularity (but only modest infiltrate and minimal intimal hyperplasia), which is partially ameliorated by intraarticular hyaluronate therapy.</abstract><cop>Pisa</cop><pub>Clinical and Experimental Rheumatology</pub><pmid>18799085</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0392-856X
ispartof Clinical and experimental rheumatology, 2008-07, Vol.26 (4), p.561-567
issn 0392-856X
1593-098X
language eng
recordid cdi_proquest_miscellaneous_69582282
source MEDLINE; Alma/SFX Local Collection
subjects Animals
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Case-Control Studies
Disease Models, Animal
Diseases of the osteoarticular system
Female
Fibrosis - drug therapy
Hyaluronic Acid - administration & dosage
Hyperplasia - drug therapy
Injections, Intra-Articular
Medical sciences
Miscellaneous. Osteoarticular involvement in other diseases
Osteoarthritis
Osteoarthritis - drug therapy
Osteoarthritis - pathology
Pharmacology. Drug treatments
Severity of Illness Index
Sheep, Domestic
Synovial Membrane - drug effects
Synovial Membrane - pathology
Viscosupplements - administration & dosage
title Synovial pathology in an ovine model of osteoarthritis : effect of intraarticular hyaluronan (Hyalgan®)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A33%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synovial%20pathology%20in%20an%20ovine%20model%20of%20osteoarthritis%20:%20effect%20of%20intraarticular%20hyaluronan%20(Hyalgan%C2%AE)&rft.jtitle=Clinical%20and%20experimental%20rheumatology&rft.au=CAKE,%20M.%20A&rft.date=2008-07-01&rft.volume=26&rft.issue=4&rft.spage=561&rft.epage=567&rft.pages=561-567&rft.issn=0392-856X&rft.eissn=1593-098X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E69582282%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69582282&rft_id=info:pmid/18799085&rfr_iscdi=true